)
Edge
Extra Everything: The Story of Chipotle
Chipotle's story from a single restaurant to a nationwide chain, through crisis and turnaround, built on one of the strongest models in the industry.
AbCellera Biologics
AbCellera Biologics (ABCL) investor relations material
AbCellera Biologics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary29 Apr, 2026
Executive summary
Annual meeting scheduled for June 11, 2026, to be held virtually for shareholders of record as of April 15, 2026.
Proxy materials, including the Notice of Meeting, Proxy Statement, and Annual Report or Form 10-K, are available online, with paper copies available upon request.
Voting matters and shareholder proposals
Election of two class III directors to serve until the 2029 Annual Meeting or until successors are duly elected and qualified.
Ratification of Ernst & Young LLP as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Advisory vote to approve the compensation of named executive officers (Say-on-Pay).
Provision to transact any other business properly brought before the meeting or any adjournment.
Board of directors and corporate governance
Board recommends voting FOR all three main proposals on the agenda.
Nominees for class III directors are John S. Montalbano, CFA, and Stephen R. Quake, D.Phil.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from AbCellera Biologics
- Shareholders will vote on directors, auditor ratification, and executive pay, with strong governance.ABCL
Proxy filing29 Apr 2026 - Lead asset ABCL635 nears pivotal phase II data for hot flashes, with up to five clinical assets by next year.ABCL2026 Bloom Burton & Co. Healthcare Investor Conference21 Apr 2026
- Advancing ABCL635 and a diversified pipeline, with strong liquidity and late-stage clinical focus.ABCL44th Annual J.P. Morgan Healthcare Conference12 Apr 2026
- Lead asset ABCL635 advances in phase II, supported by in-house manufacturing and strong funding.ABCL2026 KeyBanc Capital Markets Healthcare Forum17 Mar 2026
- Advancing a differentiated antibody pipeline with key phase II data and rapid expansion plans.ABCLTD Cowen 46th Annual Health Care Conference4 Mar 2026
- 2025 revenue surged to $75.1M, net loss narrowed, and liquidity reached $700M.ABCLQ4 202524 Feb 2026
- Revenue fell and losses widened, but liquidity and pipeline progress remained strong.ABCLQ2 20242 Feb 2026
- Transitioning to a clinical-stage biotech, advancing novel antibody therapies and leveraging AI.ABCLGoldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026
- Advancing antibody programs toward IND in 2025, backed by strong cash and pharma partnerships.ABCL2024 Wells Fargo Healthcare Conference22 Jan 2026
Next AbCellera Biologics earnings date
Q1 202611 May, 2026
AbCellera Biologics
Next AbCellera Biologics earnings date
Q1 202611 May, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
Related articles
)
)
Frequently asked questions
Explore our global coverage